secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2025-12-29T23:59:59+00:00
Accession:  0001493152-25-029364
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata raises $4.1M (up to $12.4M) in private placement at $2.04/share for OTC acne kit launch
--------------------------------------------------------------------------------

- Gross proceeds of ~$4.1M upfront; potential additional ~$8.3M from full warrant exercise for total up to $12.4M.
- Issued 2.02M shares (or pre-funded warrants) plus series C and D warrants for 2.02M shares each at $2.04 exercise price.
- Company insiders, including CEO/CFO, purchased $1.5M of shares and warrants (735K shares and 1.47M warrants).
- Net proceeds ~$3.7M; intended for OTC acne kit launch (mid-2026) and general corporate purposes, including R&D.
- Amended 120,734 outstanding warrants from Jan 2025 to $2.04 exercise price from $12.70; expires 5 years from approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000149315225029364/0001493152-25-029364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000149315225029364/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-029364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer